Details for Patent: 8,846,618
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,846,618 protect, and when does it expire?
Patent 8,846,618 protects SAXENDA and VICTOZA and is included in two NDAs.
Protection for SAXENDA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has eleven patent family members in nine countries.
Summary for Patent: 8,846,618
Title: | Stable formulation of modified GLP-1 |
Abstract: | Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof. |
Inventor(s): | Flink; James M. (Klanpenborg, DK), Larsen; Silke Moller (Charlottenlund, DK), Jensen; Simon Bjerregaard (Frederiksberg, DK), Engelund; Dorthe Kot (Holte, DK) |
Assignee: | Novo Nordisk A/S (Bagsvaerd, DK) |
Application Number: | 12/785,861 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,846,618 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Use; |
Drugs Protected by US Patent 8,846,618
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo | SAXENDA | liraglutide recombinant | SOLUTION;SUBCUTANEOUS | 206321-001 | Dec 23, 2014 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
Novo Nordisk Inc | VICTOZA | liraglutide recombinant | SOLUTION;SUBCUTANEOUS | 022341-001 | Jan 25, 2010 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,846,618
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Denmark | 2001 01010 | Jun 28, 2001 |
Denmark | 2001 01011 | Jun 28, 2001 |
Denmark | 2001 01052 | Jul 4, 2001 |
Denmark | 2001 01053 | Jul 4, 2001 |
Denmark | 2002 00093 | Jan 18, 2002 |
International Family Members for US Patent 8,846,618
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 382057 | See Plans and Pricing | |||
Australia | 2002316811 | See Plans and Pricing | |||
Germany | 60224284 | See Plans and Pricing | |||
Denmark | 1412384 | See Plans and Pricing | |||
European Patent Office | 1412384 | See Plans and Pricing | |||
Spain | 2298378 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |